David Stejskal
Agel Research and Training Institute, Czech Republic
Title: New marker of metabolic syndrome
Biography
Biography: David Stejskal
Abstract
Recently an intensive search for new indicators of metabolic syndrome and its complications. Potential, yet unmeasured indicators are CD5like and CD36 in serum. Objective: To build ELISA test and determination CD5like and CD36 in patients with metabolic syndrome. Methods: 123 subjects were examined; 65 of them suffered from metabolic syndrome (minimum of three indicators characterize metabolic syndrome). 30 healthy controls. All measured normal risk factors. CD5like and CD36 was measured in R&D laboratories Biovendor Czech Republic. Results: CD5-like linked with the number of components of metabolic syndrome (P <0.01). This parameter independently discriminated against persons with metabolic syndrome from lean individuals. CD36 with BMI values nor the number of components of the metabolic syndrome unchanged. Conclusion: The first time was measured CD-5 like in serum. It seems that this is a new parameter independent of the metabolic syndrome.